{"result": "(\"entity\"<|>GH<|>EVENT<|>GH (Growth Hormone) is a hormone whose deficiency is frequently evaluated in the context of pituitary adenomas and trauma.)\n##\n(\"entity\"<|>ACTH<|>EVENT<|>ACTH (Adrenocorticotropic Hormone) is a hormone produced by the pituitary gland, often associated with corticotropinomas and other pituitary disorders.)\n##\n(\"entity\"<|>CUSHING'S DISEASE<|>EVENT<|>Cushing's disease is a condition caused by excess ACTH, often related to pituitary adenomas, particularly corticotropinomas.)\n##\n(\"entity\"<|>MACROADENOMA<|>EVENT<|>Macroadenoma refers to a type of pituitary adenoma that is larger than 1 cm and can cause significant hormonal imbalances.)\n##\n(\"entity\"<|>KETOCONAZOLE<|>EVENT<|>Ketoconazole is a medication mentioned as a treatment option for conditions related to excess cortisol, such as Cushing's disease.)\n##\n(\"entity\"<|>HYPOTHYROIDISM<|>EVENT<|>Hypothyroidism is a condition that can occur as a result of pituitary dysfunction, often evaluated in patients with pituitary adenomas.)\n##\n(\"entity\"<|>HYPERADRENALISM<|>EVENT<|>Hyperadrenalism refers to excessive production of adrenal hormones, which can be related to pituitary adenomas producing ACTH.)\n##\n(\"entity\"<|>DIABETES INSIPIDUS<|>EVENT<|>Diabetes insipidus is a condition that can occur due to alterations in vasopressin secretion, often seen in patients with pituitary disorders.)\n##\n(\"entity\"<|>SIADH<|>EVENT<|>SIADH (Syndrome of Inappropriate Antidiuretic Hormone secretion) is a condition that can occur in the acute phase of pituitary disorders.)\n##\n(\"entity\"<|>CORTICOTROPINOMAS<|>EVENT<|>Corticotropinomas are a specific type of pituitary adenoma that secretes ACTH and can lead to Cushing's disease.)\n##\n(\"entity\"<|>HYPOTHALAMUS<|>GEO<|>The hypothalamus is a region of the brain that plays a crucial role in hormone regulation and is closely related to pituitary function.)\n##\n(\"relationship\"<|>GH<|>PITUITARY ADENOMAS<|>GH deficiency is a common evaluation in patients with pituitary adenomas, indicating a direct relationship<|>8)\n##\n(\"relationship\"<|>ACTH<|>CUSHING'S DISEASE<|>ACTH is a key hormone involved in the development of Cushing's disease, linking the two entities<|>9)\n##\n(\"relationship\"<|>CUSHING'S DISEASE<|>CORTICOTROPINOMAS<|>Corticotropinomas are a primary cause of Cushing's disease due to excess ACTH production<|>9)\n##\n(\"relationship\"<|>MACROADENOMA<|>PITUITARY ADENOMAS<|>Macroadenomas are a subtype of pituitary adenomas, indicating a direct relationship<|>8)\n##\n(\"relationship\"<|>KETOCONAZOLE<|>CUSHING'S DISEASE<|>Ketoconazole is used as a treatment for Cushing's disease, establishing a relationship between the two<|>7)\n##\n(\"relationship\"<|>HYPOTHYROIDISM<|>PITUITARY ADENOMAS<|>Hypothyroidism can occur as a result of pituitary dysfunction, linking it to pituitary adenomas<|>6)\n##\n(\"relationship\"<|>HYPERADRENALISM<|>CUSHING'S DISEASE<|>Hyperadrenalism is a condition that can result from Cushing's disease, indicating a relationship<|>7)\n##\n(\"relationship\"<|>DIABETES INSIPIDUS<|>PITUITARY ADENOMAS<|>Diabetes insipidus can occur due to pituitary disorders, linking it to pituitary adenomas<|>6)\n##\n(\"relationship\"<|>SIADH<|>PITUITARY ADENOMAS<|>SIADH can occur in the acute phase of pituitary disorders, establishing a relationship<|>6)\n##\n(\"relationship\"<|>CORTICOTROPINOMAS<|>PITUITARY ADENOMAS<|>Corticotropinomas are a specific type of pituitary adenoma, indicating a direct relationship<|>8)\n##\n(\"relationship\"<|>HYPOTHALAMUS<|>PITUITARY ADENOMAS<|>The hypothalamus regulates the pituitary gland, establishing a relationship with pituitary adenomas<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: abilidad de desarrollar alteraciones hormonales se relaciona directamente con la grave-                                                 pituitary adenomas in Sweden. J Clin Endocrinol Metab. 2013;98(2):626-35.\n              dad del trauma. La aparición de deficiencias adenohipofisarias suele ser aguda, y es mucho\n              menos frecuente su aparición tardía, a partir de los 3-12 meses tras el trauma.\n                •  El déficit de GH, evaluado mediante test de estímulo, es el más frecuente en contexto                                         15  Varón que fue intervenido hace 15 días de un macroadenoma de hipófisis de 2,5 cm,\n                   de un trauma craneal, mientras que la frecuencia de aparición de hipoadrenalismo,                                                 que infiltraba senos cavernosos. Clínicamente solo refería cefalea sin afectación\n                   hipotiroidismo e hipogonadismo es menor.                                                                                          visual y su control hormonal era normal. En la anatomía patológica informan de que\n              Las alteraciones en la secreción de vasopresina son comunes en la fase aguda, en forma de                                              la lesión es un adenoma hipofisario productor de ACTH de tipo 3. Ante este hallazgo:\n              diabetes insípida o SIADH transitorios, pero pocos casos persisten posteriormente.                                                     A. Indica tratamiento con ketoconazol.\n              Referencias:                                                                                                                           B. Informa al paciente de que tiene una enfermedad de Cushing silente.\n              • Snyder PJ. Causes of hypopituitarism. En: Cooper DS, Martin KA, eds. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.      C. Este resultado de anatomía patológica nos indica que su lesión tiene peor pronóstico\n                com (acceso 29 de abril de 2019).                                                                                                        que si hubiera sido un gonadotropinoma.\n                                                                                                                                                     D.  Las tres opciones son correctas.\n    1.3 Masas hipofisarias\n                                                                                                                                                     COMENTARIO\n       14     ¿Cuál de los siguientes tumores hipofisarios es el menos prevalente?                                                                   El paciente descrito, sin clínica sugestiva de síndrome de Cushing ni alteraciones en el\n              A. Productor de GH.                                                                                                                    estudio hormonal previo a la cirugía, no tendría una enfermedad de Cushing silente (sino un\n                                                                                                                                                     corticotropinoma silente) y desde luego no tendría indicación de tratamiento con ketocona-\n              B. Productor de gonadotrofinas.                                                                                                        zol (ya que no tiene hipercortisolismo) (respuestas A y B falsas).\n              C. Productor de ACTH.                                                                                                                    Los corticotropinomas silentes son una de las cinco categorías de adenomas hipofisa-\n              D.  Productor de TSH.                                                                                                                    rios que la OMS clasifica como clínicamente agresivas:\n                                                                                                                                                       1. Adenoma somatotropo escasamente granulado.\n              COMENTARIO                                                                                                                               2. Adenomas lactotropos en varones.\n              Los adenomas hipofisarios son tumores benignos de la hipófisis anterior y representan la causa                                           3. Adenoma de células de Crooke.\n              más frecuente de masa selar a partir de la tercera década de la vida. La prevalencia de los adeno-\n              mas hipofisarios ha sido infraestimada en la literatura científica, al considerarse tumores poco                                         4. Adenoma corticotropo silente.\n              frecuentes, pero pueden llegar a constituir hasta el 10% de todas las neoplasias intracraneales.                                         5. Adenoma plurihormonal Pit-1 positivo.\n              En estudios más recientes, la prevalencia descrita de adenomas hipofisarios ha sido hasta 4\n              veces mayor que la descrita en estudios antiguos (77,6 casos por 100.000habitantes).\n\n\n\n24                                                                                                                                                                                                                                                                            25\n---\n                                                                                                                                                                                                                          HIPÓFISIS                        1\n\n\n\n        Los corticotropinomas silentes son un subtipo biológica y patológicamente distinto de los                                   óseo (la osteoesclerosis de huesos largos es patognomónica), exoftalmos, diabetes insípida por\n        adenomas hipofisarios.           La  evidencia indica       que   estos   tumores     son   una   variante agresi-          infiltración hipofisaria, insuficiencia renal y afectación del sistema nervioso central y/o cardio-\n        va  tanto de los corticotropinomas             como de los adenomas no funcionantes (respuesta C                            vascular. Suele presentarse en adultos de 40-60 años con una relación hombre mujer 3:1. Su\n        correcta).    Mientras     que   preoperatoriamente se          pueden presentar como un adenoma                    no      pronóstico es variable, pero empeora en los casos con afectación del sistema nervioso central.\n        funcionante, necesitan ser controlados muy estrechamente en el período postoperatorio                                       Por último, la sarcoidosis es una enfermedad granulomatosa que puede afectar al h\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>SWEDEN<|>GEO<|>Sweden is a country where pituitary adenomas are studied and reported in medical literature.)\n##\n(\"entity\"<|>PITUITARY ADENOMAS<|>EVENT<|>Pituitary adenomas are benign tumors of the pituitary gland that can cause hormonal alterations and are a common subject of medical research.)\n##\n(\"entity\"<|>SNYDER PJ<|>PERSON<|>Snyder PJ is an author who has contributed to the understanding of hypopituitarism and related conditions.)\n##\n(\"relationship\"<|>SNYDER PJ<|>PITUITARY ADENOMAS<|>Snyder PJ has written about the causes and implications of pituitary adenomas in medical literature<|>7)\n##\n(\"relationship\"<|>PITUITARY ADENOMAS<|>SWEDEN<|>Research on pituitary adenomas is conducted in Sweden, indicating a connection between the country and the medical condition<|>5)\n<|COMPLETE|>"}]}